Atlas Trials

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice

Clinical trial NCT04878393 · COMPLETED

Trial details

NCT number
NCT04878393
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2021-04-30
Primary completion
2023-02-09
Enrollment
650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.